Featuring perspectives from Ms Ilene Galinsky, Dr Michael J Mauro, Dr Neil P Shah and Dr Sara M Tinsley-Vance, including the following topics:
- Introduction: Chronic Myeloid Leukemia (CML) as a Model for Targeted Treatment (0:00)
- Biology of CML; Role of First- and Second-Generation Tyrosine Kinase Inhibitors (TKIs) as Initial Treatment for Chronic-Phase (CP) CML (12:37)
- Role of Asciminib for Newly Diagnosed CP-CML (47:46)
- Feasibility of TKI Discontinuation for Patients with Sustained Response to Treatment (1:14:06)
- Management of CP-CML After Failure of Initial Therapy (1:23:04)
NCPD information and select publications
Research To Practice | Oncology Videos